Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liability, Legal | 5 | 2012 | 28 | 1.290 |
Why?
|
Professional Misconduct | 2 | 2012 | 3 | 0.880 |
Why?
|
Guidelines as Topic | 2 | 2012 | 43 | 0.860 |
Why?
|
Workplace | 2 | 2012 | 46 | 0.840 |
Why?
|
Risk Management | 2 | 2012 | 24 | 0.760 |
Why?
|
Human T-lymphotropic virus 1 | 3 | 2007 | 4 | 0.650 |
Why?
|
Social Behavior | 2 | 2008 | 58 | 0.630 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 2007 | 4 | 0.600 |
Why?
|
Employment | 3 | 2010 | 50 | 0.540 |
Why?
|
Bacteriophage T4 | 2 | 2005 | 3 | 0.510 |
Why?
|
Health Facility Administrators | 3 | 2010 | 6 | 0.500 |
Why?
|
Adenosine Triphosphatases | 2 | 2005 | 11 | 0.500 |
Why?
|
Endodeoxyribonucleases | 2 | 2004 | 3 | 0.470 |
Why?
|
Hospital Administration | 2 | 2010 | 11 | 0.470 |
Why?
|
Emergency Medical Technicians | 1 | 2012 | 11 | 0.430 |
Why?
|
Laryngeal Masks | 1 | 2012 | 15 | 0.420 |
Why?
|
Infectious Mononucleosis | 1 | 2011 | 1 | 0.410 |
Why?
|
Fusobacterium Infections | 1 | 2011 | 3 | 0.410 |
Why?
|
Pharyngitis | 1 | 2011 | 11 | 0.410 |
Why?
|
Streptococcal Infections | 1 | 2011 | 19 | 0.410 |
Why?
|
Interviews as Topic | 1 | 2012 | 240 | 0.400 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 56 | 0.400 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 70 | 0.390 |
Why?
|
Viral Proteins | 2 | 2012 | 40 | 0.380 |
Why?
|
HTLV-I Infections | 2 | 2007 | 3 | 0.370 |
Why?
|
Phenotype | 3 | 2007 | 653 | 0.370 |
Why?
|
Amino Acid Sequence | 6 | 2007 | 268 | 0.330 |
Why?
|
Molecular Sequence Data | 6 | 2007 | 340 | 0.330 |
Why?
|
Genetic Variation | 2 | 2007 | 278 | 0.320 |
Why?
|
Adenosine Triphosphate | 2 | 2005 | 46 | 0.320 |
Why?
|
Interprofessional Relations | 1 | 2008 | 47 | 0.310 |
Why?
|
Virion | 1 | 2005 | 6 | 0.280 |
Why?
|
Disasters | 1 | 2006 | 9 | 0.280 |
Why?
|
Hospitals, Community | 1 | 2006 | 10 | 0.280 |
Why?
|
Disaster Planning | 1 | 2006 | 29 | 0.270 |
Why?
|
Molecular Motor Proteins | 1 | 2005 | 73 | 0.260 |
Why?
|
Bacteriophage lambda | 1 | 2004 | 1 | 0.250 |
Why?
|
Ecosystem | 3 | 2019 | 5 | 0.240 |
Why?
|
Humans | 17 | 2019 | 28304 | 0.240 |
Why?
|
Virus Assembly | 1 | 2002 | 11 | 0.220 |
Why?
|
Health Facilities | 2 | 2012 | 11 | 0.220 |
Why?
|
Animals, Wild | 2 | 2010 | 4 | 0.190 |
Why?
|
Geographic Information Systems | 2 | 2010 | 14 | 0.190 |
Why?
|
Health Benefit Plans, Employee | 2 | 2010 | 14 | 0.190 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 95 | 0.180 |
Why?
|
Deer | 1 | 2019 | 1 | 0.180 |
Why?
|
Animal Migration | 1 | 2019 | 1 | 0.180 |
Why?
|
Hypoglycemia | 1 | 2019 | 41 | 0.180 |
Why?
|
Seizures | 1 | 2019 | 47 | 0.180 |
Why?
|
Guideline Adherence | 1 | 2019 | 110 | 0.170 |
Why?
|
Blood Glucose | 1 | 2019 | 485 | 0.150 |
Why?
|
Virus Replication | 2 | 2007 | 44 | 0.140 |
Why?
|
Cell Line | 2 | 2007 | 418 | 0.130 |
Why?
|
Sequence Alignment | 3 | 2004 | 60 | 0.130 |
Why?
|
Emergency Medical Services | 2 | 2019 | 154 | 0.130 |
Why?
|
Sequence Analysis, DNA | 2 | 2007 | 147 | 0.130 |
Why?
|
Amino Acid Motifs | 2 | 2004 | 21 | 0.120 |
Why?
|
Child, Preschool | 3 | 2012 | 1126 | 0.120 |
Why?
|
Streptococcus Phages | 1 | 2012 | 1 | 0.110 |
Why?
|
Streptococcus equi | 1 | 2012 | 1 | 0.110 |
Why?
|
Enzymes | 1 | 2012 | 5 | 0.110 |
Why?
|
Privacy | 1 | 2012 | 9 | 0.110 |
Why?
|
Videotape Recording | 1 | 2012 | 12 | 0.110 |
Why?
|
Checklist | 1 | 2012 | 33 | 0.110 |
Why?
|
Allied Health Personnel | 1 | 2012 | 3 | 0.110 |
Why?
|
Crowding | 1 | 2011 | 9 | 0.110 |
Why?
|
Manikins | 1 | 2012 | 33 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2012 | 90 | 0.110 |
Why?
|
Analgesia | 1 | 2011 | 30 | 0.100 |
Why?
|
Fusobacterium necrophorum | 1 | 2011 | 3 | 0.100 |
Why?
|
Streptococcus pyogenes | 1 | 2011 | 16 | 0.100 |
Why?
|
Equipment Design | 1 | 2012 | 161 | 0.100 |
Why?
|
Time Factors | 3 | 2011 | 1874 | 0.100 |
Why?
|
Adolescent | 3 | 2019 | 3184 | 0.100 |
Why?
|
Homing Behavior | 1 | 2010 | 1 | 0.100 |
Why?
|
Quality of Health Care | 1 | 2011 | 134 | 0.100 |
Why?
|
Workers' Compensation | 1 | 2010 | 4 | 0.100 |
Why?
|
Protein Structure, Tertiary | 2 | 2012 | 87 | 0.100 |
Why?
|
Personnel Selection | 1 | 2010 | 13 | 0.100 |
Why?
|
Family Leave | 1 | 2010 | 2 | 0.100 |
Why?
|
Pediatrics | 1 | 2012 | 130 | 0.090 |
Why?
|
Hemostatics | 1 | 2009 | 12 | 0.090 |
Why?
|
Aprotinin | 1 | 2009 | 7 | 0.090 |
Why?
|
Drug Hypersensitivity | 1 | 2009 | 8 | 0.090 |
Why?
|
Animals | 6 | 2019 | 6402 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2010 | 32 | 0.090 |
Why?
|
Behavior, Animal | 1 | 2010 | 149 | 0.090 |
Why?
|
Pain | 1 | 2011 | 247 | 0.090 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 478 | 0.090 |
Why?
|
Models, Statistical | 1 | 2010 | 157 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 73 | 0.090 |
Why?
|
Clinical Competence | 1 | 2012 | 296 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2010 | 390 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 1 | 2009 | 72 | 0.090 |
Why?
|
Organizational Policy | 1 | 2008 | 20 | 0.080 |
Why?
|
Mass Screening | 1 | 2010 | 218 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 441 | 0.080 |
Why?
|
United States | 3 | 2010 | 3588 | 0.080 |
Why?
|
Genes, pol | 1 | 2007 | 1 | 0.080 |
Why?
|
Phylogeny | 1 | 2007 | 56 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2007 | 122 | 0.070 |
Why?
|
Health Personnel | 1 | 2008 | 103 | 0.070 |
Why?
|
Prospective Studies | 1 | 2012 | 1932 | 0.070 |
Why?
|
Base Sequence | 1 | 2007 | 241 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2007 | 113 | 0.070 |
Why?
|
Female | 5 | 2019 | 17679 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2007 | 114 | 0.070 |
Why?
|
Security Measures | 1 | 2006 | 2 | 0.070 |
Why?
|
Organizational Case Studies | 1 | 2006 | 11 | 0.070 |
Why?
|
Louisiana | 1 | 2006 | 12 | 0.070 |
Why?
|
Integrases | 1 | 2005 | 2 | 0.070 |
Why?
|
Dimerization | 1 | 2005 | 23 | 0.070 |
Why?
|
Aspartic Acid | 1 | 2005 | 13 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2002 | 71 | 0.070 |
Why?
|
Mutagenesis | 1 | 2005 | 29 | 0.070 |
Why?
|
Safety Management | 1 | 2006 | 26 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2005 | 40 | 0.070 |
Why?
|
Escherichia coli | 1 | 2005 | 80 | 0.070 |
Why?
|
Genotype | 1 | 2007 | 813 | 0.060 |
Why?
|
Genome, Viral | 1 | 2004 | 12 | 0.060 |
Why?
|
Lysine | 1 | 2004 | 23 | 0.060 |
Why?
|
Male | 4 | 2019 | 16967 | 0.060 |
Why?
|
Child | 3 | 2019 | 2151 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2002 | 20 | 0.060 |
Why?
|
RNA Helicases | 1 | 2002 | 2 | 0.060 |
Why?
|
DNA Helicases | 1 | 2002 | 5 | 0.060 |
Why?
|
Threonine | 1 | 2002 | 11 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 36 | 0.060 |
Why?
|
Databases as Topic | 1 | 2002 | 24 | 0.060 |
Why?
|
Protein Subunits | 1 | 2002 | 26 | 0.060 |
Why?
|
Protein Structure, Secondary | 1 | 2002 | 41 | 0.060 |
Why?
|
Binding Sites | 1 | 2002 | 112 | 0.060 |
Why?
|
Fibroblasts | 1 | 2002 | 99 | 0.050 |
Why?
|
Telemetry | 2 | 2010 | 27 | 0.050 |
Why?
|
Mutation | 1 | 2002 | 451 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 23 | 0.050 |
Why?
|
Montana | 1 | 2019 | 1 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2019 | 51 | 0.040 |
Why?
|
Seasons | 1 | 2019 | 81 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 177 | 0.040 |
Why?
|
Infant | 2 | 2011 | 928 | 0.040 |
Why?
|
Agriculture | 1 | 2019 | 174 | 0.040 |
Why?
|
North Carolina | 1 | 2019 | 1412 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2012 | 15 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 74 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2019 | 2930 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2011 | 136 | 0.030 |
Why?
|
Needs Assessment | 1 | 2011 | 64 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2011 | 114 | 0.030 |
Why?
|
Acute Disease | 1 | 2011 | 234 | 0.020 |
Why?
|
Tax Exemption | 1 | 2010 | 2 | 0.020 |
Why?
|
Radiography | 1 | 2011 | 339 | 0.020 |
Why?
|
Income Tax | 1 | 2010 | 3 | 0.020 |
Why?
|
Labor Unions | 1 | 2010 | 2 | 0.020 |
Why?
|
Federal Government | 1 | 2010 | 10 | 0.020 |
Why?
|
Databases, Factual | 1 | 2011 | 320 | 0.020 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2010 | 15 | 0.020 |
Why?
|
Pain Measurement | 1 | 2011 | 328 | 0.020 |
Why?
|
Occult Blood | 1 | 2010 | 7 | 0.020 |
Why?
|
Vaginal Smears | 1 | 2010 | 9 | 0.020 |
Why?
|
Government Regulation | 1 | 2010 | 30 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 26 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 37 | 0.020 |
Why?
|
Mammography | 1 | 2010 | 37 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2010 | 59 | 0.020 |
Why?
|
Skin Tests | 1 | 2009 | 15 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2011 | 142 | 0.020 |
Why?
|
Drug Eruptions | 1 | 2009 | 8 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 23 | 0.020 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2009 | 7 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2011 | 194 | 0.020 |
Why?
|
Disabled Persons | 1 | 2010 | 78 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2009 | 48 | 0.020 |
Why?
|
Data Collection | 1 | 2010 | 158 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 221 | 0.020 |
Why?
|
Research Design | 1 | 2010 | 271 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 1345 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2009 | 587 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 206 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 1285 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 438 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 2004 | 3 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2004 | 13 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2004 | 100 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2010 | 655 | 0.010 |
Why?
|
Templates, Genetic | 1 | 2002 | 3 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 32 | 0.010 |
Why?
|
Chick Embryo | 1 | 2002 | 61 | 0.010 |
Why?
|
Chickens | 1 | 2002 | 39 | 0.010 |
Why?
|
Plasmids | 1 | 2002 | 48 | 0.010 |
Why?
|
Exons | 1 | 2002 | 54 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 2321 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 169 | 0.010 |
Why?
|
RNA | 1 | 2002 | 83 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2010 | 3562 | 0.010 |
Why?
|
DNA | 1 | 2002 | 207 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 779 | 0.010 |
Why?
|
Adult | 1 | 2009 | 8243 | 0.010 |
Why?
|
Aged | 1 | 2010 | 9256 | 0.010 |
Why?
|
Middle Aged | 1 | 2010 | 10678 | 0.010 |
Why?
|